id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dhrp-67	Rao, Sohail; Singh, Manish	Paxlovid Rebound: Proposed Strategy to Prevent Reinfection Following Treatment of COVID-19 Positive Nonhospitalized Patients 	2022	9	.pdf	application/pdf	1853	106	20	In a recent study involving 13,600 patients, it was reported that 7-day and 30-day COVID-19 rebound rates after Paxlovid treatment were 3.53% and 5.40% for SARS-CoV-2 infection, 2.31% and 5.87% for COVID-19 symptoms, and 0.44% and 0.77% for hospitalizations (8). Rebound of COVID-19 symptoms following the use of Paxlovid treatment is likely due to insufficient drug exposure: not enough of the drug was getting to infected cells to stop all viral replication.	cache/dhrp-67.pdf	txt/dhrp-67.txt